Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 25NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Central Nervous System Neoplasms 38Head and Neck Neoplasms 32Lung Neoplasms 31Squamous Cell Carcinoma of Head and Neck 28Lymphoma 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Breast Neoplasms 18Brain Neoplasms 18Leukemia 15Glioblastoma 15Sarcoma 13Gliosarcoma 13Uterine Cervical Neoplasms 12Astrocytoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Adenocarcinoma of Lung 11Burkitt Lymphoma 10Rhabdomyosarcoma 9Neoplasm Metastasis 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Rectal Neoplasms 8Radiation Injuries 8Oligodendroglioma 8Esophageal Neoplasms 8Colorectal Neoplasms 8Adenocarcinoma Of Esophagus 8Urinary Bladder Neoplasms 6Stomach Neoplasms 6

Interventions

Whole-Body Irradiation 2Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Daunorubicin 2Cytarabine 2Asparaginase 2ruxolitinib 1merphos 1hydrocortisone hemisuccinate 1fludarabine phosphate 1fludarabine 1asparaginase erwinia chrysanthemi recombinant 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Photopheresis 1Pentostatin 1Patient Reported Outcome Measures 1Moxifloxacin 1Morphine 1Mitoxantrone 1Methoxsalen 1Mesna 1Melphalan 1Leyk 1In Situ Hybridization, Fluorescence 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Myeloproliferative Disorders × Radiotherapy × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡